Yueling Liao

1.2k total citations
25 papers, 710 citations indexed

About

Yueling Liao is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yueling Liao has authored 25 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in Yueling Liao's work include Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related Molecular Pathways (4 papers). Yueling Liao is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (4 papers) and Cancer-related Molecular Pathways (4 papers). Yueling Liao collaborates with scholars based in China, Thailand and United States. Yueling Liao's co-authors include Jiong Deng, Hongyong Song, Wenzheng Guo, Beibei Sun, Tong Wang, Bo Jing, Kaimi Li, Feng Yao, Ling Jing and Yanbin Kuang and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Yueling Liao

25 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yueling Liao China 16 425 234 206 131 121 25 710
Tao Pan China 11 315 0.7× 227 1.0× 157 0.8× 122 0.9× 94 0.8× 22 627
Shangke Huang China 13 421 1.0× 274 1.2× 244 1.2× 69 0.5× 110 0.9× 28 743
Xiaoqian Jing China 19 442 1.0× 185 0.8× 221 1.1× 94 0.7× 105 0.9× 32 680
Shucai Yang China 13 509 1.2× 230 1.0× 317 1.5× 95 0.7× 154 1.3× 24 793
Zhimin Liu China 15 357 0.8× 241 1.0× 213 1.0× 68 0.5× 100 0.8× 32 741
Ursula Cesta Incani Italy 7 489 1.2× 187 0.8× 188 0.9× 106 0.8× 51 0.4× 9 703
Wan-Ju Kim United States 15 559 1.3× 267 1.1× 209 1.0× 112 0.9× 65 0.5× 26 819
Suk‐young Lee South Korea 16 395 0.9× 216 0.9× 148 0.7× 111 0.8× 60 0.5× 43 719
Minna Luo China 12 465 1.1× 314 1.3× 233 1.1× 67 0.5× 87 0.7× 28 723

Countries citing papers authored by Yueling Liao

Since Specialization
Citations

This map shows the geographic impact of Yueling Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueling Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueling Liao more than expected).

Fields of papers citing papers by Yueling Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueling Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueling Liao. The network helps show where Yueling Liao may publish in the future.

Co-authorship network of co-authors of Yueling Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Yueling Liao. A scholar is included among the top collaborators of Yueling Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueling Liao. Yueling Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wen, Donghua, Xiang Song, Min Hu, et al.. (2025). NF-κB-mediated EAAT3 upregulation in antioxidant defense and ferroptosis sensitivity in lung cancer. Cell Death and Disease. 16(1). 124–124. 3 indexed citations
2.
Wang, Tong, Bo Jing, Dongliang Xu, et al.. (2020). PTGES/PGE2 signaling links immunosuppression and lung metastasis in Gprc5a-knockout mouse model. Oncogene. 39(15). 3179–3194. 56 indexed citations
3.
Guo, Wenzheng, Yanbin Kuang, Jingjing Wu, et al.. (2020). Hexokinase 2 Depletion Confers Sensitization to Metformin and Inhibits Glycolysis in Lung Squamous Cell Carcinoma. Frontiers in Oncology. 10. 52–52. 13 indexed citations
4.
Jing, Bo, Tong Wang, Beibei Sun, et al.. (2019). IL6/STAT3 Signaling Orchestrates Premetastatic Niche Formation and Immunosuppressive Traits in Lung. Cancer Research. 80(4). 784–797. 77 indexed citations
5.
Kuang, Yanbin, Wenzheng Guo, Ling Jing, et al.. (2019). Iron-dependent CDK1 activity promotes lung carcinogenesis via activation of the GP130/STAT3 signaling pathway. Cell Death and Disease. 10(4). 297–297. 46 indexed citations
6.
Guo, Wenzheng, Min Hu, Jingjing Wu, et al.. (2019). Gprc5a depletion enhances the risk of smoking-induced lung tumorigenesis and mortality. Biomedicine & Pharmacotherapy. 114. 108791–108791. 12 indexed citations
7.
Hu, Min, Wenzheng Guo, Yueling Liao, et al.. (2019). Dysregulated ENPP1 increases the malignancy of human lung cancer by inducing epithelial-mesenchymal transition phenotypes and stem cell features.. PubMed. 9(1). 134–144. 32 indexed citations
8.
Wang, Tong, Bo Jing, Beibei Sun, et al.. (2019). Stabilization of PTGES by deubiquitinase USP9X promotes metastatic features of lung cancer via PGE2 signaling.. PubMed. 9(6). 1145–1160. 28 indexed citations
9.
Li, Kaimi, Wenzheng Guo, Zhanming Li, et al.. (2019). ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage. Neoplasia. 21(6). 602–614. 55 indexed citations
10.
Wang, Tong, Kaimi Li, Hongyong Song, et al.. (2019). p53 suppression is essential for oncogenic SPAG5 upregulation in lung adenocarcinoma. Biochemical and Biophysical Research Communications. 513(2). 319–325. 20 indexed citations
11.
Song, Hongyong, Beibei Sun, Yueling Liao, et al.. (2018). GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development. International Journal of Cancer. 144(4). 777–787. 21 indexed citations
12.
Liu, Shuli, Dongxia Ye, Tong Wang, et al.. (2017). Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma. Cancer Cell International. 17(1). 34–34. 27 indexed citations
13.
Liu, Shuli, Lei Shi, Xi Yang, et al.. (2017). Nuclear survivin promoted by acetylation is associated with the aggressive phenotype of oral squamous cell carcinoma. Cell Cycle. 16(9). 894–902. 19 indexed citations
14.
Liu, Shuli, Liu Liu, Weimin Ye, et al.. (2016). High Vimentin Expression Associated with Lymph Node Metastasis and Predicated a Poor Prognosis in Oral Squamous Cell Carcinoma. Scientific Reports. 6(1). 38834–38834. 59 indexed citations
15.
Liu, Shuli, Dongxia Ye, Wenzheng Guo, et al.. (2015). G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget. 6(9). 6887–6901. 99 indexed citations
16.
Zhang, Chen, Xiaoli Shan, Yueling Liao, et al.. (2014). Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients. BMC Complementary and Alternative Medicine. 14(1). 474–474. 33 indexed citations
17.
Liu, Jinyi, Yueling Liao, Kewei Ma, et al.. (2013). PI3K is required for the physical interaction and functional inhibition of NF-κB by β-catenin in colorectal cancer cells. Biochemical and Biophysical Research Communications. 434(4). 760–766. 19 indexed citations
18.
Lü, Rong, et al.. (2012). [Research progress of sarcolipin-a new regulatory protein of sarcoplasmic reticulum Ca2+ ATPase].. PubMed. 37(3). 316–9. 1 indexed citations
19.
Guo, Wei, et al.. (2012). [Effect of Leonurus stachydrine on myocardial cell hypertrophy].. PubMed. 35(6). 940–3. 15 indexed citations
20.
Liao, Yueling, et al.. (1996). Autoantibodies against ADP/ATP carrier from patients with dilated cardiomyopathy increase activity of voltage-dependent Ca channels in isolated cardiac myocytes.. PubMed. 3. 41–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026